| Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS (NCT07095686) | n-Lorem Foundation | 2024-10-02 |
| Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma (NCT06160206) | Academic and Community Cancer Research United | 2024-10-02 |
| NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy (NCT06403267) | NoNO Inc. | 2024-10-02 |
| Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age (NCT06618196) | LG Chem | 2024-10-02 |
| Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) (NCT06684379) | PEACHES BIOTECH | 2024-10-02 |
| Physiology of Unloading VA ECMO Trial (NCT06336655) | University of Utah | 2024-10-02 |
| A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer (NCT06568692) | Processa Pharmaceuticals | 2024-10-02 |
| Vitiligo, New Treatment and Serum s100B (NCT06768840) | South Valley University | 2024-10-02 |
| The Anesthetic and Analgesic Effect of Adjunct Liposomal Bupivacaine in Periodontal Surgical Procedures (NCT07725731) | The University of Texas Health Science Center at San Antonio | 2024-10-02 |
| A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy (NCT06568237) | Teva Branded Pharmaceutical Products R&D LLC | 2024-10-02 |
| PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC (NCT06742424) | West China Hospital | 2024-10-01 |
| Antiviral Clinical Trial for Long Covid-19 (NCT06511063) | Icahn School of Medicine at Mount Sinai | 2024-10-01 |
| A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk. (NCT06630871) | Fujian Medical University Union Hospital | 2024-10-01 |
| Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC (NCT06863506) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-10-01 |
| Endoscopic Retrograde Cholangiopancreatography With Radiofrequency Ablation (ERCP-RFA) Combined With Envafolimab and Surufatinib Sequential Therapy for Unresectable Biliary Tract Carcinoma (NCT06656559) | Tianjin Medical University Cancer Institute and Hospital | 2024-10-01 |
| Efficacy of Traumatic Memory Modification Using Memory Reconsolidation and Propranolol Among Adolescents With PTSD (NCT04921982) | Rennes University Hospital | 2024-10-01 |
| Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC (NCT06222593) | State University of New York at Buffalo | 2024-10-01 |
| Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems (NCT07480096) | Indonesia University | 2024-10-01 |
| Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma (NCT06485908) | Assistance Publique Hopitaux De Marseille | 2024-10-01 |
| VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS (NCT06471946) | Navy General Hospital, Beijing | 2024-10-01 |
| Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer (NCT06599775) | Shanghai Zhongshan Hospital | 2024-10-01 |
| Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction (NCT06306638) | Roswell Park Cancer Institute | 2024-10-01 |
| SB: Promoting Bone Health in Women (NCT06843486) | Instituto Politécnico de Bragança | 2024-10-01 |
| Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer (NCT06775678) | Tianjin Medical University Cancer Institute and Hospital | 2024-10-01 |
| Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases (NCT04889066) | University of Texas Southwestern Medical Center | 2024-10-01 |
| Cranioplasty Using Titanium Mesh vs Bone Cement (NCT06662903) | Osman Hassan Osman Zafraan | 2024-10-01 |
| Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection (NCT06626555) | University College, London | 2024-10-01 |
| Citicoline in Youth Alcohol Use Disorder (NCT05870111) | Medical University of South Carolina | 2024-10-01 |
| Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic (NCT06497543) | Hunan Province Tumor Hospital | 2024-10-01 |
| Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma (NCT06675201) | Sichuan University | 2024-10-01 |
| High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly (NCT06345495) | M.D. Anderson Cancer Center | 2024-10-01 |
| A Study to Test Different Doses of BI 1569912 in People With Depression (NCT06558344) | Boehringer Ingelheim | 2024-10-01 |
| A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis (NCT06671054) | SynAct Pharma Aps | 2024-10-01 |
| A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks. (NCT06602284) | Equipmed USA LLC | 2024-10-01 |
| A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL (NCT06516978) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-01 |
| Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma (NCT06505551) | SCG Cell Therapy Pte. Ltd. | 2024-10-01 |
| Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal Cancer (NCT06596343) | Sir Run Run Shaw Hospital | 2024-10-01 |
| Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer (NCT06554535) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2024-10-01 |
| Cilostazol in Parkinson's Disease (NCT06612593) | Ain Shams University | 2024-10-01 |
| Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) (NCT06806930) | George Washington University | 2024-10-01 |
| Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery (NCT06530524) | Sir Mortimer B. Davis - Jewish General Hospital | 2024-10-01 |
| Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?! (NCT06608186) | Ahmed Saad | 2024-10-01 |
| Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis (NCT06257537) | ZetrOZ, Inc. | 2024-10-01 |
| Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRT (NCT06598917) | China Medical University Hospital | 2024-10-01 |
| Evaluation of iPRF With Vit.D As an Adjunct to Non-Surgical Therapy in the Treatment of Stage III Periodontitis (NCT06570200) | Cairo University | 2024-10-01 |
| Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas (NCT06176027) | Navy General Hospital, Beijing | 2024-10-01 |
| Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer (NCT06600841) | Fujian Cancer Hospital | 2024-10-01 |
| Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer (NCT05849129) | The Canadian College of Naturopathic Medicine | 2024-10-01 |
| Black Seed Oil in ADHD (NCT06542887) | Ain Shams University | 2024-10-01 |
| A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity (NCT06595238) | AstraZeneca | 2024-10-01 |
| Sonodynamic-Chemoradiotherapy Integration in Glioblastoma (NCT07130149) | Yingjuan Zheng | 2024-10-01 |
| Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis (NCT06999148) | Yingjuan Zheng | 2024-10-01 |
| Organoid-based Functional Precision Therapy for Advanced Breast Cancer (NCT06102824) | Guangdong Provincial People's Hospital | 2024-10-01 |
| Lidocaine Versus Magnesium Sulphate in Management of Myofascial Pain Dysfunction Syndrome (NCT06595017) | Misr University for Science and Technology | 2024-10-01 |
| Motivational Interviewing Intervention For Risky Drinking Treatment Among Indigenous Population (NCT06583356) | Department of Public Health Medicine, MARA University of Technology | 2024-10-01 |
| Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis (NCT06623513) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2024-10-01 |
| 177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer (NCT06329830) | Baptist Health South Florida | 2024-10-01 |
| Node-Sparing Short-Course Radiation With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer: A Randomized, Prospective, Multicenter Study (NCT06594692) | Sir Run Run Shaw Hospital | 2024-10-01 |
| Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment (NCT06592612) | Sun Yat-sen University | 2024-10-01 |
| Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy. (NCT06506955) | Taiho Oncology, Inc. | 2024-10-01 |
| Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors (NCT07492693) | Changhai Hospital | 2024-10-01 |
| Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC (NCT06552234) | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | 2024-10-01 |
| Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement (NCT06594432) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-01 |
| A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer (NCT05563766) | VA Office of Research and Development | 2024-10-01 |
| Use of Antibiotic Based Irrigation for Ureteroscopic Treatment of Urolithiasis (NCT06007352) | Yale University | 2024-10-01 |
| Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) (NCT06160791) | Jerry Lee, MD, MSc, MPhil | 2024-10-01 |
| Precise Neoadjuvant Chemoresection of Low Grade NMIBC (NCT06227065) | University of Bern | 2024-10-01 |
| High Or Low Dose pOstpartUm Oxytocin at the Time of Cesarean Birth (NCT06550089) | University of Chicago | 2024-10-01 |
| Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention (NCT06111885) | Insel Gruppe AG, University Hospital Bern | 2024-10-01 |
| High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI (NCT06652048) | Jialei Wang | 2024-10-01 |
| SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt (NCT06588179) | Fudan University | 2024-10-01 |
| Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients (NCT06620393) | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 2024-10-01 |
| Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study (NCT06663059) | Tang-Du Hospital | 2024-10-01 |
| Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms (NCT02638701) | University of California, San Francisco | 2024-10-01 |
| Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD (NCT05333029) | Molly Gallogly | 2024-10-01 |
| AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC (NCT06196814) | Hunan Province Tumor Hospital | 2024-10-01 |
| Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder (NCT06116045) | Biozeus Biopharmaceutical S.A. | 2024-10-01 |
| Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC (NCT06648525) | Harbin Medical University | 2024-10-01 |
| Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block (NCT06899841) | Assiut University | 2024-10-01 |
| A Randomized, Placebo-controlled Trial of Prednisone in Refractory Restless Legs Syndrome: a Pilot Study (NCT06631300) | Scripps Health | 2024-10-01 |
| Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection (NCT07279792) | Ain Shams University | 2024-10-01 |
| A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC (NCT06585644) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-10-01 |
| TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia. (NCT06602323) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2024-10-01 |
| Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection (NCT06546111) | Sadat City University | 2024-10-01 |
| Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC) (NCT05518032) | Roswell Park Cancer Institute | 2024-10-01 |
| Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia (NCT06657391) | Rongrong Liu | 2024-10-01 |
| Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial (NCT06262048) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2024-10-01 |
| Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI (NCT06441045) | Fujian Cancer Hospital | 2024-10-01 |
| 68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI (NCT07209865) | First Affiliated Hospital of Fujian Medical University | 2024-10-01 |
| Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33) (NCT06273527) | University of California, San Diego | 2024-10-01 |
| Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects (NCT06471543) | Ikaria Bioscience Pty Ltd | 2024-09-30 |
| A Study on TLC590 for Managing Postsurgical Pain (NCT06574269) | TLC Biopharmaceuticals, Inc. | 2024-09-30 |
| Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma (NCT07243626) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-09-30 |
| Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury. (NCT06617182) | Yongquan Shi | 2024-09-30 |
| A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC) (NCT06590246) | Shanghai AbelZeta Ltd. | 2024-09-30 |
| Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer (NCT05628610) | Fujian Cancer Hospital | 2024-09-30 |
| Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer (NCT06085755) | Jeeyun Lee | 2024-09-30 |
| Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma (NCT06044311) | Melissa Lumish | 2024-09-30 |
| Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A) (NCT06293300) | University of Miami | 2024-09-30 |
| The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule (NCT06621082) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-09-30 |